Lehigh Valley Health Network hit by cyber attack. Here’s the patient info hackers stole

Reuters

Sandoz launches rival version of AbbVie’s arthritis drug Humira

The Novartis-owned company said its drug, Hyrimoz, will be priced at a 5% discount off Humira’s current list price of $6,922 per month, but that it was also offering an unbranded version of Humira at an 81% discount. Healthcare experts have said that drugmakers will probably launch their Humira biosimilars with small discounts to appeal to pharmacy benefit managers, which take some of their fees as a percentage of the discounts they negotiate on behalf of their customers – large employers and health insurance plans.